When we talk about the opioid epidemic, so many of our conversations are focused on the companies involved. Who made what, delivered it where and in what quantity? What weren’t we, the people, told and why? It sounds simple on its face, but the details and legal ramifications are knotty. Unraveling them is challenging work.